Bill Snyder

January 28, 2021

Study’s findings may help eventually close the door on COVID-19

Researchers at Vanderbilt University Medical Center and the University of Texas Medical Branch (UTMB) at Galveston have discovered what may be the Achilles’ heel of the coronavirus, a finding that may help close the door on COVID-19 and possibly head off future pandemics.

By Bill Snyder
Cholesterol
January 21, 2021

NIH grant bolsters research on heart disease, cholesterol

Thanks to major funding from the National Institutes of Health (NIH), researchers at Vanderbilt University Medical Center have made major inroads in understanding how high-density lipoprotein (HDL), commonly known as good cholesterol, in some cases may actually contribute to the development of atherosclerosis.

By Bill Snyder
Pneumonia bacteria
January 21, 2021

Study finds genetic clues to pneumonia risk and COVID-19 disparities

Researchers at Vanderbilt University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences.

By Bill Snyder
January 14, 2021

Bick selected as first VUMC Discovery Scholar in Health and Medicine

Alexander Bick, MD, PhD, assistant professor of Medicine in the Division of Genetic Medicine at Vanderbilt University Medical Center, has been selected as the first VUMC Discovery Scholar in Health and Medicine.

By Bill Snyder
January 6, 2021

Genome editing technique “rescues” mice from accelerated aging disorder: study

Researchers from the Broad Institute of Harvard and MIT, the National Institutes of Health (NIH) and Vanderbilt University Medical Center for the first time have used a novel genome-editing technique to “rescue” mice from progeria, a rare genetic disease that causes accelerated aging.

By Bill Snyder
January 5, 2021

VUMC, Case Western apply artificial intelligence to “customize” oral cancer treatment

Researchers at Vanderbilt University Medical Center and Case Western Reserve University in Cleveland have been awarded a five-year, $3.3 million grant by the National Cancer Institute to apply artificial intelligence (AI) to help customize treatment for oral cancer patients.

By Bill Snyder
December 17, 2020

Clinic uses new weapon to treat high-risk COVID patients

Vanderbilt University Medical Center has a new weapon in the fight against COVID-19 — an investigational antibody treatment approved last month for emergency use in COVID-19 outpatients at high risk of developing severe disease or requiring hospital care.
By Bill Snyder
December 17, 2020

Heart failure study seeks to reduce hospitalizations

A national study led by researchers at Vanderbilt University Medical Center has found that many patients who arrive at the emergency department (ED) with acute heart failure can be safely discharged with self-care guidance and frequent phone appointments, avoiding the need for hospitalization.
By Bill Snyder
December 16, 2020

Coronavirus ‘crusaders’ spur VUMC research achievements

The development of the vaccines, monoclonal antibodies and antiviral drugs that ultimately will defeat COVID-19 wouldn’t have been possible had it not been for the unflagging and selfless efforts of a global army of research nurses, laboratory personnel, recruiters and other staff.
By Bill Snyder
December 15, 2020

A deeper look at out-of-home care

Geographically targeted efforts to prevent children being placed in out-of-home care might be possible, Vanderbilt researchers report.
By Bill Snyder
December 10, 2020

Exploiting viral vulnerabilities

The isolation of human monoclonal antibodies against dangerous viruses including EEEV, Hendra and Nipah could offer new ways to treat and prevent these infections.
By Bill Snyder
December 10, 2020

Study sheds light on diabetes and COVID interaction

COVID-19 has been linked to cases of new-onset diabetes, diabetes-related emergencies and a higher death rate among diabetes patients.
By Bill Snyder
1 … 27 28 29 30 31 … 110